A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects

NCT04859452 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: DBPR108 tablets
DRUG: Metformin hydrochloride tablets
DRUG: Glibenclamide tablets
DRUG: Valsartan Capsules
DRUG: Simvastatin tablets

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.